1. Home
  2. NLSP vs TCI Comparison

NLSP vs TCI Comparison

Compare NLSP & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • TCI
  • Stock Information
  • Founded
  • NLSP 2015
  • TCI 1983
  • Country
  • NLSP Switzerland
  • TCI United States
  • Employees
  • NLSP N/A
  • TCI N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • TCI Real Estate
  • Sector
  • NLSP Health Care
  • TCI Finance
  • Exchange
  • NLSP Nasdaq
  • TCI Nasdaq
  • Market Cap
  • NLSP 12.4M
  • TCI 239.1M
  • IPO Year
  • NLSP 2021
  • TCI N/A
  • Fundamental
  • Price
  • NLSP $2.31
  • TCI $43.47
  • Analyst Decision
  • NLSP
  • TCI
  • Analyst Count
  • NLSP 0
  • TCI 0
  • Target Price
  • NLSP N/A
  • TCI N/A
  • AVG Volume (30 Days)
  • NLSP 378.8K
  • TCI 6.9K
  • Earning Date
  • NLSP 07-15-2025
  • TCI 08-07-2025
  • Dividend Yield
  • NLSP N/A
  • TCI N/A
  • EPS Growth
  • NLSP N/A
  • TCI 59.61
  • EPS
  • NLSP N/A
  • TCI 0.92
  • Revenue
  • NLSP N/A
  • TCI $47,452,000.00
  • Revenue This Year
  • NLSP N/A
  • TCI N/A
  • Revenue Next Year
  • NLSP N/A
  • TCI N/A
  • P/E Ratio
  • NLSP N/A
  • TCI $50.36
  • Revenue Growth
  • NLSP N/A
  • TCI N/A
  • 52 Week Low
  • NLSP $1.30
  • TCI $25.50
  • 52 Week High
  • NLSP $15.59
  • TCI $46.74
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 48.87
  • TCI 56.95
  • Support Level
  • NLSP $2.20
  • TCI $43.44
  • Resistance Level
  • NLSP $3.08
  • TCI $46.23
  • Average True Range (ATR)
  • NLSP 0.25
  • TCI 1.80
  • MACD
  • NLSP -0.05
  • TCI -0.22
  • Stochastic Oscillator
  • NLSP 16.36
  • TCI 61.03

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: